Medscape: Skin adverse events rare after immunotherapy to treat skin cancers
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found certain skin adverse events were rare following immunotherapy treatments for certain skin cancers.
"Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors are commonly used drugs for the treatment of various cancers," said Pushkar Aggarwal, MD, corresponding author and medical resident/fellow in UC's College of Medicine. "Having knowledge regarding possible associated skin reactions is vital for clinicians to guide management of the skin reaction and whether an adjustment is needed for the PD-1/PD-L1 inhibitors."
The researchers reviewed adverse event reports for patients treated with PD-1 and PD-L1 treatments between January 2004 and May 2023 to identify whether significant signals exist between PD-1/PD-L1 inhibitors and skin tumors keratoacanthoma and cutaneous squamous cell carcinoma (cSCC).
"For both keratoacanthoma and cSCC, significant signals were found with PD-1/PD-L1 inhibitors," Aggarwal said. But, out of 158,000 cases in the review, the data showed only 43 patients developing keratocanthoma and 83 developing cSCC, which highlights the conditions are "relatively rare adverse events."
Aggarwal said case reports, case-control trials and randomized clinical trials are needed to confirm the results of this study.
Featured photo at top of metastatic melanoma cells. Photo/National Cancer Institute.
Latest UC News
- Pianist, educator and scholar Lynn Worcester Jones joins CCM’s facultyUC College-Conservatory of Music Interim Dean Jonathan Kregor has announced the addition of Lynn Worcester Jones, DMA, to the college’s roster of distinguished performing and media arts faculty members. Jones is an innovative pianist, educator, writer, speaker, mentor and leader who encourages career preparation and excellence in students. She begins her new role as Associate Professor of Piano Pedagogy and Coordinator of Group Piano at CCM on Aug. 15, 2024.
- Residents concerned about high concentration of low-income housingEfforts to build more affordable housing in Cincinnati have created concerns for residents as low-income housing has been concentrated in some of the city’s poorest neighborhoods, WCPO reported. Gary Painter, PhD, the academic director of the University of Cincinnati’s Carl H. Lindner College of Business real estate program and a professor of real estate, said a complaint against the city could lead to positive outcomes.
- Is ketamine the answer to treatment-resistant depression?The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
- Scientists craft bold plan to unlock secrets of RNAUC Vice President for Research Patrick Limbach is a key figure in the National Academies’ massive undertaking to sequence RNA in the next 15 years.
- Fellowship aimed at diversifying the nursing workforce celebrates a meaningful milestoneTo help prepare and expand a nursing workforce that is reflective of and responsive to an increasingly diverse patient population, UC College of Nursing launched its Cultivating Undergraduate Nursing Resilience and Equity (CURE) program in the fall of 2021.
- GE Aerospace expands Next Engineers program for Cincinnati youthGE Aerospace Foundation is investing further in its Next Engineers program, including the Cincinnati location facilitated by the University of Cincinnati, extending the program locally through 2028. Engineering Academy, a three-year engineering education program for high-schoolers, graduated its first cohort of students. Students who complete the program and go on to pursue an engineering degree in college will receive a scholarship.